Literature DB >> 1329972

Time-dependent utilization of platelet arachidonic acid by the neutrophil in formation of 5-lipoxygenase products in platelet-neutrophil co-incubations.

C Antoine1, R C Murphy, P M Henson, J Maclouf.   

Abstract

The biosynthesis of leukotrienes is known to occur through a series of complex processes which, in part, can be influenced by cell-cell interactions. Several studies have suggested that arachidonic acid availability is a major limiting step for leukotriene biosynthesis and that its transfer between cells can represent a significant source of this precursor. Accordingly, effect of time and source of arachidonic acid on transcellular leukotriene synthesis was studied in mixed platelet/neutrophil populations challenged with the calcium ionophore A23187. A time-dependent contribution of platelet-derived as well as neutrophil-derived arachidonate was found in the selective formation of neutrophil 5-lipoxygenase metabolites. Utilization of platelet or neutrophil arachidonate was followed by incorporation of radiolabeled arachidonic acid into platelet or neutrophil phospholipids prior to stimulation. Specific activity of liberated arachidonic acid along with numerous 5-lipoxygenase products (including LTB4, 20-hydroxy-LTB4, 5-HETE and LTC4) was determined in order to follow mass and radiolabel. A large amount of platelet-derived arachidonic acid was released in the first 1.5 min, whereas 10 min platelet-derived arachidonate was much lower in amount but significantly higher in specific activity, suggesting different precursor pools. The platelet-derived arachidonate was heavily utilized by the neutrophils at the early time points for formation of 5-HETE and delta 6-trans-LTB4 isomers, but appeared to contribute only marginally to the constitutive metabolism of neutrophil arachidonate into LTB4. Results from these experiments suggest different pools of 5-lipoxygenase in the neutrophil and indicate a time and source dependent modulation of arachidonate metabolism in mixed cell interactions.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1329972     DOI: 10.1016/0005-2760(92)90299-b

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  6 in total

1.  Cysteinyl leukotriene overproduction in aspirin-exacerbated respiratory disease is driven by platelet-adherent leukocytes.

Authors:  Tanya M Laidlaw; Molly S Kidder; Neil Bhattacharyya; Wei Xing; Shiliang Shen; Ginger L Milne; Mariana C Castells; Heng Chhay; Joshua A Boyce
Journal:  Blood       Date:  2012-01-18       Impact factor: 22.113

2.  Technical Advance: Changes in neutrophil migration patterns upon contact with platelets in a microfluidic assay.

Authors:  Galit H Frydman; Anna Le; Felix Ellett; Julianne Jorgensen; James G Fox; Ronald G Tompkins; Daniel Irimia
Journal:  J Leukoc Biol       Date:  2016-09-14       Impact factor: 4.962

3.  Decreased arachidonic acid metabolism in human platelets by autologous neutrophils: possible role of cell adhesion.

Authors:  B Chabannes; P Molière; Y Pacheco; M Lagarde
Journal:  Biochem J       Date:  1994-06-15       Impact factor: 3.857

4.  Cutting edge: Leukotriene C4 activates mouse platelets in plasma exclusively through the type 2 cysteinyl leukotriene receptor.

Authors:  Hannah E Cummings; Tao Liu; Chunli Feng; Tanya M Laidlaw; Pamela B Conley; Yoshihide Kanaoka; Joshua A Boyce
Journal:  J Immunol       Date:  2013-11-15       Impact factor: 5.422

Review 5.  The role of platelets in the recruitment of leukocytes during vascular disease.

Authors:  G Ed Rainger; Myriam Chimen; Matthew J Harrison; Clara M Yates; Paul Harrison; Stephen P Watson; Marie Lordkipanidzé; Gerard B Nash
Journal:  Platelets       Date:  2015-07-21       Impact factor: 3.862

6.  Complement Factor C5a Is Increased in Blood of Patients with Abdominal Aortic Aneurysm and Has Prognostic Potential for Aneurysm Growth.

Authors:  Branislav Zagrapan; Wolf Eilenberg; Andreas Scheuba; Johannes Klopf; Annika Brandau; Julia Story; Katharina Dosch; Hubert Hayden; Christoph M Domenig; Lukas Fuchs; Rüdiger Schernthaner; Robin Ristl; Ihor Huk; Christoph Neumayer; Christine Brostjan
Journal:  J Cardiovasc Transl Res       Date:  2020-12-17       Impact factor: 4.132

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.